Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris. (Q54137742)

25 May 2018

title

Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris. (English)

1 reference

25 May 2018

1 reference

1 reference

J J Leyden

1

1 reference

25 May 2018

A R Shalita

series ordinal

2

1 reference

25 May 2018

G D Saatjian

series ordinal

3

1 reference

25 May 2018

J Sefton

series ordinal

4

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 April 1987

1 reference

25 May 2018

Journal of the American Academy of Dermatology

published in

1 reference

25 May 2018

volume

16

1 reference

25 May 2018

issue

4

1 reference

25 May 2018

page(s)

822-827

1 reference

25 May 2018

Microbiology of comedones in acne vulgaris.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

THE PATHOGENIC ROLE OF CORYNEBACTERIUM ACNES IN ACNE VULGARIS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Genesis of free fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Comedogenicity of human sebum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

The Chemoattractant Properties of Comedonal Components

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Systemic Antibiotics for Treatment of Acne Vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Effect of orally administered antibacterial agents on titratable acidity of human sebum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

The effect of antimicrobial agents on leukocyte chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Topically applied erythromycin in inflammatory acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Topical erythromycin vs blank vehicle in a multiclinic acne study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Nonparametric analysis of covariance by matching

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Topical antibacterial therapy for acne. Study of the family of erythromycins

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Topical erythromycin solution in acne. Results of a multiclinic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970107-8

7 January 2021

10.1016/S0190-9622(87)70107-8

Identifiers

DOI

1 reference

25 May 2018

PubMed ID

2952685

1 reference

25 May 2018